As per the scheme of arrangement, the pharmaceutical undertaking of the company is demerged and transferred to Alembic Pharmaceuticals with effect from 01 April 2010. Hence, the current quarter and full year ended March 2011 are not comparable with the corresponding previous quarter and full year ended March 2010.